1)Rootman J:Why“orbital pseudotumor”is no longer a useful concept. Br J Ophthalmol 82:339-340, 1998
2)Yuen SJ, Rubin PA:Idiopathic orbital inflammation. Arch Ophthalmol 121:491-499, 2003
3)Mombaerts I, Koornneef L:Current status in the treatment of orbital myosis. Ophthalmology 104:402-408, 1997
4)Suhler EB, Lim LL, Beardsley RM et al:Rituximab therapy for refractory orbital inflammation results of a phase 1/2, dose-ranging, randomized clinical trial. JAMA Ophthalmol 132:572-578, 2014
5)Savino G, Battendieri R, Siniscalco A et al:Intraorbital injection of rituximab in idiopathic orbital inflammatory syndrome:case report. Rheumatol Int 35:138-188, 2015
6)Shah SS, Lowder CY, Schmitt MA et al:Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 99:1419-1423, 1992
7)Smith JR, Rosenbaum JT:A role for methotrexate in the management of non-infectious orbital inflammatory disease. Br J Ophthalmol 85:1220-1224, 2001
8)Eagle K, King A, Fisher C et al:Cyclophosphamide induced remission in relapsed, progressive idiopathic orbital inflammation(pseudotumor). Clinical Oncology 7:402-404, 1995
9)Roman JS, Aguilar JMV, Ferrer JB et al:Idiopathic orbital myositis:treatment with cyclosporine. Ann Rheum Dis 52:84-85, 1993
10)Austin HA 3rd, Klippel JH, Balow JE et al:Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619, 1986
11)Kovarsky J:Clinical pharmacology and toxicology of cyclophosphamide:emphasis on use in rheumatic diseases. Semin Arthritis Rheum 12:359-372, 1983
12)Ponticelli C, Zucchelli Passerini et al:A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med 320:8-13, 1989
13)Brummair T, Pohanka E, Pieringer H et al:Using cyclophosphamide in inflammatory rheumatic diseases. Eur J Intern Med 24:590-596, 2013
14)Okada AA:Immunomodulatory therapy for ocular inflammatory disease. A basic manual and review of the literature. Ocul Immunol Inflamm 13:335-351, 2005